cas 82534-54-1|| where to buy 1-(cyclobutylmethyl)piperazine

Nom du produit:1-(cyclobutylmethyl)piperazine

IUPAC Name:1-(cyclobutylmethyl)piperazine

Unité d'emballage	Stock disponible	Prix($)
CM132716-100mg	in stock	Ƅư
CM132716-250mg	in stock	ĽȎĽ
CM132716-1g	in stock	ưźƄ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 82534-54-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:82534-54-1; Formule moléculaire:C9H18N2; Point de fusion:-; Code SMILES:N1(CC2CCC2)CCNCC1; Densité:

: Numéro de catalogue:CM132716; Poids moléculaire:154.26; Point d'ébullition:; N° Mdl:MFCD04605372; Stockage:Store at 2-8°C.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.